Plaque Psoriasis Study in Pediatric Subjects

Completed · Phase 4 · Has a placebo group

Conditions studied: Plaque Psoriasis

In brief

The purpose of this study is to compare the safety, efficacy and calcium metabolism of up to 8 weeks of treatment with calcitriol 3 mcg/g ointment versus its vehicle, when used twice daily, without occlusion, to treat children aged 2 to 12 years, with plaque psoriasis.

Key facts

Study ID
NCT02186665
Run by
Galderma R&D
People needed
19
Starts
2014-07-01
Expected to finish
2016-01-01
Last updated by the study team
2021-02-18

Who can join

Age: 2 and older, up to 12. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.